Maroulio Talieri

2.2k total citations
57 papers, 1.9k citations indexed

About

Maroulio Talieri is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Maroulio Talieri has authored 57 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 30 papers in Molecular Biology and 20 papers in Genetics. Recurrent topics in Maroulio Talieri's work include Peptidase Inhibition and Analysis (20 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (19 papers) and Protease and Inhibitor Mechanisms (10 papers). Maroulio Talieri is often cited by papers focused on Peptidase Inhibition and Analysis (20 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (19 papers) and Protease and Inhibitor Mechanisms (10 papers). Maroulio Talieri collaborates with scholars based in Greece, Canada and Germany. Maroulio Talieri's co-authors include Andreas Scorilas, Alexandros Ardavanis, Theoni Trangas, Eleftherios P. Diamandis, Hellinida Thomadaki, Niki Arnogiannaki, Niki Agnanti, Andreas Karameris, Marina Devetzi and Konstantinos V. Floros and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Biochemical and Biophysical Research Communications and Annals of the New York Academy of Sciences.

In The Last Decade

Maroulio Talieri

57 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maroulio Talieri Greece 27 1.1k 683 528 494 197 57 1.9k
Kazushi Shigemasa Japan 27 840 0.8× 636 0.9× 441 0.8× 421 0.9× 249 1.3× 50 1.8k
Sanjeeva Mohanam United States 26 1.1k 1.0× 738 1.1× 1.3k 2.4× 241 0.5× 390 2.0× 53 2.2k
Jennifer Callahan United States 11 467 0.4× 294 0.4× 402 0.8× 290 0.6× 330 1.7× 19 1.0k
Steven Pirie‐Shepherd United States 19 815 0.8× 356 0.5× 398 0.8× 99 0.2× 138 0.7× 36 1.4k
Dorina Belotti Italy 26 1.3k 1.2× 897 1.3× 779 1.5× 104 0.2× 147 0.7× 43 2.4k
Douglas W. McMillin United States 25 1.2k 1.1× 837 1.2× 263 0.5× 234 0.5× 642 3.3× 57 2.1k
Carmela Calés Spain 18 1.3k 1.2× 370 0.5× 196 0.4× 251 0.5× 178 0.9× 34 2.0k
Keng‐Hsueh Lan Taiwan 13 1.5k 1.4× 1.5k 2.3× 325 0.6× 215 0.4× 63 0.3× 21 2.5k
Nicolaï Grebenchtchikov Netherlands 17 486 0.4× 340 0.5× 353 0.7× 224 0.5× 264 1.3× 25 1.1k

Countries citing papers authored by Maroulio Talieri

Since Specialization
Citations

This map shows the geographic impact of Maroulio Talieri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maroulio Talieri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maroulio Talieri more than expected).

Fields of papers citing papers by Maroulio Talieri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maroulio Talieri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maroulio Talieri. The network helps show where Maroulio Talieri may publish in the future.

Co-authorship network of co-authors of Maroulio Talieri

This figure shows the co-authorship network connecting the top 25 collaborators of Maroulio Talieri. A scholar is included among the top collaborators of Maroulio Talieri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maroulio Talieri. Maroulio Talieri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Devetzi, Marina, et al.. (2019). Uncovering the clinical impact of kallikrein-related peptidase 5 (KLK5) mRNA expression in the colorectal adenoma-carcinoma sequence. Clinical Chemistry and Laboratory Medicine (CCLM). 57(8). 1251–1260. 10 indexed citations
2.
Michaelidou, Kleita, et al.. (2018). Human kallikrein-related peptidase 12 (KLK12) splice variants discriminate benign from cancerous breast tumors. Clinical Biochemistry. 58. 78–85. 11 indexed citations
3.
Kontos, Christos K., Konstantinos Mavridis, Maroulio Talieri, & Andreas Scorilas. (2013). Kallikrein-related peptidases (KLKs) in gastrointestinal cancer: Mechanistic and clinical aspects. Thrombosis and Haemostasis. 110(9). 450–457. 36 indexed citations
5.
Scorilas, Andreas, Alexandros Ardavanis, Peggy Lymberi, et al.. (2011). Clinical evaluation of PRMT1 gene expression in breast cancer. Tumor Biology. 32(3). 575–582. 71 indexed citations
6.
Scorilas, Andreas, et al.. (2009). Colon cancer and protein arginine methyltransferase 1 gene expression.. PubMed. 29(4). 1361–6. 54 indexed citations
7.
Scorilas, Andreas, et al.. (2006). The role of human tissue kallikreins 7 and 8 in intracranial malignancies. Biological Chemistry. 387(12). 1607–1612. 26 indexed citations
8.
Floros, Konstantinos V., Maroulio Talieri, & Andreas Scorilas. (2006). Topotecan and methotrexate alter expression of the apoptosis-related genes BCL2, FAS and BCL2L12 in leukemic HL-60 cells. Biological Chemistry. 387(12). 1629–33. 20 indexed citations
9.
10.
Paraskevas, E., et al.. (2004). SR-A1, a member of the human pre-mRNA splicing factor family, and its expression in colon cancer progression. Biological Chemistry. 385(9). 785–90. 8 indexed citations
11.
Ioannidis, Panayotis, Christine Kottaridi, Maroulio Talieri, et al.. (2004). Expression of the RNA-binding protein CRD-BP in brain and non-small cell lung tumors. Cancer Letters. 209(2). 245–250. 33 indexed citations
12.
Scorilas, Andreas, Stelios Fotiou, Evangelos Tsiambas, et al.. (2002). Determination of Cathepsin B Expression May Offer Additional Prognostic Information for Ovarian Cancer Patients. Biological Chemistry. 383(7-8). 1297–303. 40 indexed citations
13.
Παπαδοπούλου, Σοφία, et al.. (2002). Significance of Urokinase-Type Plasminogen Activator and Plasminogen Activator Inhibitor-1 (PAI-1) Expression in Human Colorectal Carcinomas. Tumor Biology. 23(3). 170–178. 19 indexed citations
14.
Talieri, Maroulio, et al.. (2001). Development of a quantitative luminometric hybridization assay for the determination of telomerase activity. Clinical Biochemistry. 34(4). 277–284. 11 indexed citations
15.
Scorilas, Andreas, Andreas Karameris, Niki Arnogiannaki, et al.. (2001). Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negative patients. British Journal of Cancer. 84(11). 1488–1496. 226 indexed citations
16.
Scorilas, Andreas, Margot H. Black, Maroulio Talieri, & Eleftherios P. Diamandis. (2000). Genomic Organization, Physical Mapping, and Expression Analysis of the Human Protein Arginine Methyltransferase 1 Gene. Biochemical and Biophysical Research Communications. 278(2). 349–359. 65 indexed citations
17.
Scorilas, Andreas, et al.. (1999). Predictive value of c-erbB-2 and cathepsin-D for Greek breast cancer patients using univariate and multivariate analysis.. PubMed. 5(4). 815–21. 28 indexed citations
19.
Scorilas, Andreas, et al.. (1998). Poly(A)polymerase activity levels in breast tumour cytosols.. PubMed. 17(4). 511–8. 10 indexed citations
20.
Scorilas, Andreas, et al.. (1994). Cathepsin-D and c-erb-B 2 have an additive prognostic value for breast cancer patients.. PubMed. 13(5C). 1895–900. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026